121 related articles for article (PubMed ID: 34376628)
1. Prognostic Analysis of Primary Pulmonary Malignant Mesenchymal Tumors Treated Surgically.
Sayan M; Kankoc A; Ozkan D; Celik A; Kurul IC; Tastepe AI
J Chest Surg; 2021 Oct; 54(5):356-360. PubMed ID: 34376628
[TBL] [Abstract][Full Text] [Related]
2. Oncological results in primary and secondary malignant chest wall tumors.
Kocaman G; Kahya Y; Konuk Balcı BM; Yenigün BM; Özkan M; Özakıncı H; Karasoy D; Yüksel C; Enön S; Kayı Cangır A
Turk Gogus Kalp Damar Cerrahisi Derg; 2024 Jan; 32(1):55-61. PubMed ID: 38545355
[TBL] [Abstract][Full Text] [Related]
3. The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
Lee CY; Byun CS; Lee JG; Kim DJ; Cho BC; Chung KY; Park IK
World J Surg Oncol; 2012 Jan; 10():9. PubMed ID: 22236955
[TBL] [Abstract][Full Text] [Related]
4. [Primary retroperitoneal tumors. Treatment modality and prognostic factors].
Boneschi M; Erba M; Cusmai F; Eusebio D; Miani S; Bortolani EM
Minerva Chir; 1999 Nov; 54(11):763-8. PubMed ID: 10638149
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of primary pulmonary sarcomas.
Bacha EA; Wright CD; Grillo HC; Wain JC; Moncure A; Keel SB; Donahue DM; Mathisen DJ
Eur J Cardiothorac Surg; 1999 Apr; 15(4):456-60. PubMed ID: 10371121
[TBL] [Abstract][Full Text] [Related]
6. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
[TBL] [Abstract][Full Text] [Related]
7. Soft-tissue sarcomas of the chest wall: prognostic factors.
Gross JL; Younes RN; Haddad FJ; Deheinzelin D; Pinto CA; Costa ML
Chest; 2005 Mar; 127(3):902-8. PubMed ID: 15764774
[TBL] [Abstract][Full Text] [Related]
8. Primary gastrointestinal sarcomas: analysis of prognostic variables.
Conlon KC; Casper ES; Brennan MF
Ann Surg Oncol; 1995 Jan; 2(1):26-31. PubMed ID: 7834450
[TBL] [Abstract][Full Text] [Related]
9. Outcome after surgical resections of recurrent chest wall sarcomas.
Wouters MW; van Geel AN; Nieuwenhuis L; van Tinteren H; Verhoef C; van Coevorden F; Klomp HM
J Clin Oncol; 2008 Nov; 26(31):5113-8. PubMed ID: 18794540
[TBL] [Abstract][Full Text] [Related]
10. Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection.
Sciubba DM; De la Garza Ramos R; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Bettegowda C; Gokaslan ZL; Wolinsky JP
Neurosurg Focus; 2016 Aug; 41(2):E9. PubMed ID: 27476851
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of primary sarcoma of the lung.
Porte HL; Metois DG; Leroy X; Conti M; Gosselin B; Wurtz A
Eur J Cardiothorac Surg; 2000 Aug; 18(2):136-42. PubMed ID: 10925220
[TBL] [Abstract][Full Text] [Related]
12. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.
Ren YJ; She YL; Dai CY; Jiang GN; Fei K; Chen C
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):321-6. PubMed ID: 26705302
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection.
Voltolini L; Rapicetta C; Luzzi L; Ghiribelli C; Ligabue T; Paladini P; Gotti G
Lung Cancer; 2006 Jun; 52(3):359-64. PubMed ID: 16644062
[TBL] [Abstract][Full Text] [Related]
14. Surgical Outcomes and Risk Analysis of Primary Pulmonary Sarcoma.
Yamada Y; Kaplan T; Soltermann A; Schmitt-Opitz I; Schneiter D; Weder W; Inci I
Thorac Cardiovasc Surg; 2021 Jan; 69(1):101-108. PubMed ID: 31499540
[TBL] [Abstract][Full Text] [Related]
15. Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter.
Collaud S; Stork T; Schildhaus HU; Pöttgen C; Plönes T; Valdivia D; Zaatar M; Dirksen U; Bauer S; Aigner C
J Surg Oncol; 2020 Sep; 122(3):506-514. PubMed ID: 32410271
[TBL] [Abstract][Full Text] [Related]
16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
17. Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis.
Lococo F; Rapicetta C; Cardillo G; Stefani A; Margaritora S; Leuzzi G; Rossi G; Petracca Ciavarella L; Morandi U; Facciolo F; Ricchetti T; Cesario A; Paci M
Ann Thorac Surg; 2017 Apr; 103(4):1142-1150. PubMed ID: 28027731
[TBL] [Abstract][Full Text] [Related]
18. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
[TBL] [Abstract][Full Text] [Related]
19. Massive chest wall resection and reconstruction for malignant disease.
Foroulis CN; Kleontas AD; Tagarakis G; Nana C; Alexiou I; Grosomanidis V; Tossios P; Papadaki E; Kioumis I; Baka S; Zarogoulidis P; Anastasiadis K
Onco Targets Ther; 2016; 9():2349-58. PubMed ID: 27143930
[TBL] [Abstract][Full Text] [Related]
20. Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas.
Kachroo P; Pak PS; Sandha HS; Lee C; Elashoff D; Nelson SD; Chmielowski B; Selch MT; Cameron RB; Holmes EC; Eilber FC; Lee JM
J Thorac Oncol; 2012 Mar; 7(3):552-8. PubMed ID: 22307013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
